Drugs / Liftactiv B3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05327361 | Mar 2022 → Jan 2023 | acne, hyperpigmentation of the skin | University of Miami | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liftactiv B3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05327361 ↗ |
| Route | Topical | “Participants will apply a dime size amount of the serum to 1 side of the face.” NCT05327361 ↗ |